Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245922 | SCV000301681 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Color Diagnostics, |
RCV000582287 | SCV000687714 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001432679 | SCV001635454 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679138 | SCV001863889 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582287 | SCV004849191 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV004591104 | SCV005084806 | benign | Familial cancer of breast | 2024-06-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |